China Universal Asset Management Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
6,913
+1,880
+37% +$404K 0.1% 146
2026
Q1
$1.09M Sell
5,033
-2,073
-29% -$460K 0.08% 181
2025
Q4
$1.62M Sell
7,106
-3,800
-35% -$866K 0.12% 133
2025
Q3
$2.53M Sell
10,906
-5,131
-32% -$1.04M 0.21% 93
2025
Q2
$2.98M Sell
16,037
-616
-4% -$114K 0.28% 74
2025
Q1
$3.49M Buy
16,653
+1,077
+7% +$209K 0.32% 67
2024
Q4
$2.77M Buy
15,576
+9,231
+145% +$1.7M 0.26% 82
2024
Q3
$1.25M Buy
6,345
+3,603
+131% +$672K 0.14% 126
2024
Q2
$470K Sell
2,742
-803
-23% -$133K 0.07% 151
2024
Q1
$646K Buy
+3,545
New +$611K 0.08% 162

Other funds holding ABBV

China Universal Asset Management Company's ABBV Position: Q2 2026 in Review

China Universal Asset Management Company increased its AbbVie (ABBV) stake by 37% in Q2 2026, buying an estimated $404K and bringing the position to 6,913 shares worth $1.74M. The position accounts for 0.1% of the portfolio, ranked #146.

China Universal Asset Management Company first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.49M in Q1 2025. 2,661 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • China Universal Asset Management Company held 6,913 shares of AbbVie worth $1.74M as of Q2 2026.
  • China Universal Asset Management Company bought 1,880 AbbVie shares in Q2 2026, an estimated $404K.
  • AbbVie made up 0.1% of China Universal Asset Management Company's portfolio in Q2 2026, its #146 holding.
  • China Universal Asset Management Company first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • China Universal Asset Management Company's AbbVie position peaked at $3.49M in Q1 2025.
  • 2,661 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.